Transfusion transmitted leishmaniasis: A case report and review of literature

Indian Journal of Medical Microbiology

Volumn 24, Issue 3, 2006, Pages 165-170

  Dey, A ^a   Singh, S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Blood bank; India; Kala azar; Mode of transmission; Transfusion transmitted

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIMONY GLUCONATE;

ARTICLE; BIRTH; BLOOD DONOR; BLOOD TRANSFUSION; CASE REPORT; CAUSE OF DEATH; CHILD; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; FEVER; HEPATOSPLENOMEGALY; HUMAN; INDIA; LABORATORY; LEISHMANIASIS; MALE; SEXUAL INTERCOURSE; VERTICAL TRANSMISSION;

EID: 33748205004     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.
2. World Health Organisation. Communicable diseases surveillance and response. Leishmaniasis. Available at:〈http://www.who.int/emc/diseases/ Leish/Leisgeo.html〉.
3. Sanyal RK. Leishmaniasis. In: Chang KP, Bray RS (editors): Leishmaniasis in the Indian sub-continent. Elsevier Science Publishers: Amsterdam; 1985. p. 443-67.
4. de Beer P, El-Harith A, Van Grootheest M, Winkler A. Outbreak of Kala-azar in the Sudan. Lancet 1990;535:224.
5. Meinecke CK, Schottelius J, Oskam L, Fleischer B. Congenital Transmission of Visceral Leishmaniasis (Kala-Azar) from an asymptomatic mother to her child. Pediatrics 1999;104:e65.
6. Symmers WS. Leishmaniasis acquired by contagion: A case of marital infection in Britain. Lancet 1960;1:127-32.
7. Amela C, Lopez-Gay D, Alberdi JC Castilla J. Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients. Eur J Epidemiol 1996;12:91-2.
8. Herwaldt BL, Juranek DD. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis and toxoplasmosis. Am J Trop Med Hyg 1993;48:313-23.
9. Andre R, Brumpt L, Dreytus B, Puseleg A, Jacob S. Leishmaniose Cutanee. Leishmaniose cutanee- ganglionnare et kala-azar transfusional. Trop Dis Bull 1958;55:379-81.
10. Kostman R, Barr M, Bengtson E, Garnham PC, Hult G. Kalaazar transferred by exchange blood transfusion in two Swedish infants. In: Proceedings of the seventh international congress of tropical medicine and malaria. World Health Organization: Geneva, Switzerland; 1963. p. 384.
11. Cohen C, Corazza F, Moll PD, Brasseur D. Leishmaniasis acquired in Belgium. Lancet 1991;338:128.
12. Cummins D, Amin S, Halil O, Chiodini PL, Hewitt PE, Radley-Smith R. Visceral leishmaniasis after cardiac surgery. Arch Dis Child 1995;72:235-6.
13. Singh S, Chaudhry VP, Wali JP. Transfusion-transmitted kalaazar in India. Transfusion 1996;36:848-9.
14. Luz KG, da Silva VO, Gomes EM, Machado FC, Araujo MA, Fonseca H, et al. Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients. Am J Trop Med Hyg 1997;57:168-71.
15. Doddridge DD. AABB recommendations regarding reducing the possible risk of transmission of Leishmania tropica by transfusion. Arlington Va: American association of blood banks. 1991.
16. Xavier B. USA blocks blood donation in bid to prevent leishmaniasis. Lancet Infect Dis 2003;3.
17. Singh S, Kumari V, Singh N. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detecting antibodies against recombinant k-39 antigen. Clin Diag Lab Immunol 2002;9:568-72.
18. Singh S, Gilman-Sacks A, Chang KP, Reed SG. Diagnostic and prognostic value of rK39 antigen in Indian Leishmaniasis. J Parasitol 1995;81:1000-3.
19. Rocha Filho FD, Ferreira FV, Mendes Fde O, Ferreira FN, Karbage A, Alencar ML, et al. Bone marrow fibrosis (pseudomyelofibrosis) in human kala-azar. Rev Soc Bras Med Trop 2000;33:363-6.
20. Singh S. New Developments in diagnosis of leishmaniasis. Indian J Med Res, 2006; 123: 311-30.
21. Schreiber GB, Busch MP, Kleinman SH, Koreiltz JJ. The risk of transfusion-transmitted viral infections. N Eng J Med 1996;334:1685-90.
22. Wells L, Ala FA. Malaria and Blood Transfusion. Lancet 1985;1:1317-8.
23. Siegel SE, Lunde MN, Gelderman AH, Halterman RH, Brown JA, Levine AS, et al. Transmission of Toxoplasmosis by leukocyte transfusion. Blood 1971;37:388-94.
24. Popovsky MA. Transfusion-transmitted Babesiosis. Transfusion 1991;31:296-8.
25. Mcgill Parasitology. Leishmania. Available at: http://martin. parasitology.mcgill.ca/jimspage/biol/leish.htm
26. Otero AC, Valdemir OD, Kleber GL, Marcos P, Claude P, Octavia F, et al. Short report:Occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors. Am J Trop Med Hyg 2000;62:128-31.
27. Chandra J, Rai RN, Mittal SK, Sharma D. Kala-azar without hepatosplenomegaly. Indian Pediatr 1991;28:1185-6.
28. Grogl M, Daugirda JL, Hoover DL, Magill AJ, Berman JD. Survivability and infectivity of viscerotropic Leishmania tropica from operation Desert Storm participants in human blood products maintained under blood bank conditions. Am J Trop Med Hyg 1993;49:308-15.
29. Guevara P, Ramirez JL, Rojas L, Scorza JV, Gonzales N, Anez N. Leishmania braziliensis in blood 30 years after cure. Lancet 1993;341:1341.
30. Guevara P, Rojas L, Gonzales N, Scorza JV, Anez N, Valera M, et al. Presence of Leishmania braziliensis in blood samples from cured patients or at different stages of immunotherapy. Clin Diagn Lab Immun 1994;1:385-9.
31. Chung HL, Chow KK, Lu JP. The first two cases of transfusion kala-azar. Chin Med J 1948;66:325-6.
32. Sivakumar R, Sharma P, Chang KP, Singh S. Cloning, Expression and Purification of a Novel recombinant antigen from Leishmania donovani. Protein Exp Purif 2005 Sep, Protein Expr Purif. 2006; 46:156-65.